Bioidentical hormones – what are they?

Bioidentical hormones – what are they?

Bio-identical hormones, also known as bioidentical hormones or compounded hormones, are a topic of interest in hormone replacement therapy (HRT). These hormones are synthesized to have the same molecular structure as hormones naturally produced by the human body. Here’s a brief overview to help you understand bio-identical hormones:

  1. Definition and Sources:
  1. Bio-identical hormones are hormones that are derived from natural sources, typically soy or yam plants. They are then processed to match the chemical structure of the hormones naturally produced by the human body, such as estradiol (a form of estrogen) and progesterone.
  2. Reference: Holtorf, K. (2009). The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? Postgraduate Medicine, 121(1), 73-85.
  1. Customized Compounding:
  1. One key feature of bio-identical hormones is their customization. Compounding pharmacies can tailor these hormones to meet an individual patient’s specific hormonal needs based on laboratory testing.
  2. Reference: Baber, R., & Panay, N. (2005). The use of bioidentical hormone replacement therapy in menopause and menopausal symptoms. The Medical Journal of Australia, 183(10), 514-515.
  1. Clinical Applications:
  1. Bio-identical hormones are used primarily in hormone replacement therapy to address hormonal imbalances, manage menopausal symptoms, and optimize hormone levels in cases of deficiency.
  2. Reference: Santoro, N., & Pinkerton, J. V. (2019). Compounded Bioidentical Hormone Therapy: Time for a Reality Check? Menopause, 26(12), 1327-1328.
  1. Benefits:
  1. Bio-identical hormones have been proposed to provide benefits such as symptom relief (e.g., hot flashes, mood swings), improved quality of life, and potentially a reduced risk of certain health conditions associated with hormonal imbalances.
  2. Reference: Gambacciani, M., & Levancini, M. (2014). Hormone replacement therapy and the prevention of postmenopausal osteoporosis. Przeglad Menopauzalny, 13(4), 213-220.
  1. Safety Considerations:
  1. The safety of bio-identical hormones remains a subject of debate. While some proponents argue that they may carry fewer risks than synthetic hormones, rigorous long-term studies are needed to establish their safety profile conclusively.
  2. Reference: Fournier, A., et al. (2008). Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Research and Treatment, 107(1), 103-111.
  1. Regulatory Oversight:
  1. Bio-identical hormones may not undergo the same regulatory scrutiny as pharmaceutical-grade synthetic hormones. Therefore, it is crucial for healthcare providers to work with reputable compounding pharmacies and consider regulatory guidelines.
  2. Reference: FDA. (2019). Compounded Bioidentical Hormone Replacement Therapy. U.S. Food and Drug Administration.
  1. Individualized Approach:
  1. The use of bio-identical hormones requires an individualized approach, taking into account a patient’s medical history, current health status, and specific hormonal needs.
  2. Reference: American College of Obstetricians and Gynecologists. (2016). Compounded bioidentical menopausal hormone therapy. ACOG Committee Opinion No. 532. Obstetrics & Gynecology, 127(6), e164-e167.

In summary, bio-identical hormones offer a personalized approach to hormone replacement therapy. While they may have advantages in certain clinical scenarios, their safety and efficacy compared to synthetic hormones require further research and consideration. Healthcare providers should engage in informed discussions with patients, considering individual needs and regulatory guidelines when considering bio-identical hormone therapy.

Scroll to Top